recombinant mouse hgf Search Results


95
R&D Systems mouse recombinant active hgf protein
Mouse Recombinant Active Hgf Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Protein/pmc09870088-213-32-40
Average 95 stars, based on 1 article reviews
mouse recombinant active hgf protein - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
R&D Systems recombinant mouse hgf
Recombinant Mouse Hgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Protein/pmc02154440-203-10-15
Average 94 stars, based on 1 article reviews
recombinant mouse hgf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Beijing Solarbio Science recombinant mouse hepatocyte growth factor
Recombinant Mouse Hepatocyte Growth Factor, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF%2FHepatopoietin-A%2FHepatocyte+Growth+Factor/pm36284313-181-30-38
Average 90 stars, based on 1 article reviews
recombinant mouse hepatocyte growth factor - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
R&D Systems hepatocyte growth factor
Hepatocyte Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Protein%2C+CF/pmc03896586-218-18-24
Average 92 stars, based on 1 article reviews
hepatocyte growth factor - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Kingfisher Biotech recombinant protein standards il 6
Recombinant Protein Standards Il 6, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Mouse+IL-6+Recombinant+Protein/pmc05701847-97-102-110
Average 93 stars, based on 1 article reviews
recombinant protein standards il 6 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems recombinant mouse hgf a
Key Resource Table
Recombinant Mouse Hgf A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Activator+Protein%2C+CF/pmc10249109-759-86-89
Average 93 stars, based on 1 article reviews
recombinant mouse hgf a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems recombinant hgfa
Fig. 5. Loss of TRPM7 impairs activation of the mTOR signaling and induction of GAlert in MuSCs. (A) Time course for induction of Trpm7 deficiency and isolation of myofibers. (B and C) Analysis of MuSCs on myofibers cultured for 30 h. (B) MuSC size: Representative YFP-positive MuSC images and size distribution (>100 cells per condi- tion). (C) pS6: Representative fluorescent images and quantification of pS6 intensity (>50 cells per condition, N = 3 mice). (D) Time course for induction of Trpm7 defi- ciency, injection of CTX, and isolation of myofibers. MuSCs on myofibers without injury was defined as quiescent satellite cells (QSCs). MuSCs on myofibers isolated from the contralateral leg of injury was defined as contralateral satellite cells (CSCs). Myofibers were isolated 4 days after CTX injection for GAlert induction. (E) Morphological evaluation of MuSCs after induction of GAlert. Phase contrast images of con (top) and cKO (bottom) MuSCs. Size distribution of QSCs and CSCs (>100 MuSCs per condition; data are individually plotted.). (F) pS6 in QSCs and CSCs: Representative images and quantification in con and cKO MuSCs (>50 cells per condition, N > 3 mice). (G) FACS histograms of MitoTracker and PyroninY staining. Gray: Unstained MuSCs; blue: con QSCs; green: con CSCs; red: cKO CSCs. (H) Time course for induction of Trpm7 defi- ciency, injection of <t>HGFA,</t> and isolation of myofibers. MuSCs from HGFA-treated mice were defined as HGFA for GAlert induction. PBS was used for control. (I) HGFA effect on pS6 in cKO MuSCs: Representative images and quantification of pS6 in con and cKO MuSCs after GAlert induction with HGFA (>50 cells per condition, N = 3 mice). Scale bars, 10 μm in [(B), (C), (E), (F), and (I)].
Recombinant Hgfa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Activator+Protein%2C+CF/pm40184450-359-0-4
Average 93 stars, based on 1 article reviews
recombinant hgfa - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems recombinant mouse hgf propeptide protein
Figure 3. Inhibition of MET and <t>HGF-activation</t> in CRTC2 cells, in vitro analysis. (A) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were then treated with each agent (final concentration of 250 nM for MET-I and 10 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of mouse <t>recombinant</t> pro-HGF (50 ng/mL). After incubation at 37 ◦C for 2 h, the proteins were extracted. Phosphorylation of MET and expression of total-MET, HGF, and α-tubulin were determined by immunoblot analysis. (B) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were seeded in a 96-well plate at a density of 1 × 104 cells/100 µL in FBS-free DMEM. The cells were then treated with each agent (final concentration of 20 µM for MET-I and 20 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of 50 ng/mL mouse recombinant pro-HGF, and incubated at 37 ◦C for 48 h. Cell proliferation was analyzed by detecting the absorbance at 490 nm and calculated as a ratio to the absorbance at day 0 (before administration, ** p < 0.01).
Recombinant Mouse Hgf Propeptide Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Recombinant+Mouse+HGF+Propeptide+Protein%2C+CF/pm40076928-272-0-14
Average 93 stars, based on 1 article reviews
recombinant mouse hgf propeptide protein - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio c met
Figure 3. Inhibition of MET and <t>HGF-activation</t> in CRTC2 cells, in vitro analysis. (A) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were then treated with each agent (final concentration of 250 nM for MET-I and 10 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of mouse <t>recombinant</t> pro-HGF (50 ng/mL). After incubation at 37 ◦C for 2 h, the proteins were extracted. Phosphorylation of MET and expression of total-MET, HGF, and α-tubulin were determined by immunoblot analysis. (B) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were seeded in a 96-well plate at a density of 1 × 104 cells/100 µL in FBS-free DMEM. The cells were then treated with each agent (final concentration of 20 µM for MET-I and 20 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of 50 ng/mL mouse recombinant pro-HGF, and incubated at 37 ◦C for 48 h. Cell proliferation was analyzed by detecting the absorbance at 490 nm and calculated as a ratio to the absorbance at day 0 (before administration, ** p < 0.01).
C Met, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/Mouse+HGF+R%2Fc-MET+Recombinant+Protein/pm41624789-289-36-37
Average 90 stars, based on 1 article reviews
c met - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mitsubishi Tanabe recombinant mouse hgf
OPN inhibits <t>HGF-</t> and PDGF-induced cellular events associated with FAK phosphorylation. (A, B) MC3T3-E1 Tet-on OPN cell lines were incubated with or without 2 μg/ml DOXY for 48 h and untreated or treated with either HGF (15 ng/ml) for 20 min or PDGF (10 ng/ml) for 10 min. The prepared cell lysates were separated by SDS–PAGE, and Western blotting was performed with the indicated antibodies. Significant difference from the control by Student’s t test (* p < 0.01). (C, D) MC3T3-E1 cells were treated with 100 ng/ml <t>recombinant</t> OPN protein for 6 h, followed by stimulation and analysis as in A and B. (E) MC3T3-E1 Tet-on OPN cell lines were treated with DOX for 48 h, followed by stimulation with HGF for 2 h. HGF-induced Vdr expression was evaluated by real-time RT-PCR. The same experiments were performed at least three times, producing consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (F) MC3T3-E1 cells were pretreated with OPN for 6 h and analyzed as in E. (G) MC3T3-E1 cells were treated with OPN for 3 h, followed by stimulation with 10 ng/ml mouse recombinant PDGF for 30 min. Cells were seeded on fibronectin-coated dishes and fixed with 10% formaldehyde at 60 min. Cells were stained to visualize the cytoplasm by eosin solution. Ten attached cells were randomly selected to measure the cell-spreading area using ImageJ software. Error bars represent SD. Statistical significance was determined by Student’s t test (* p < 0.01). (H, I) MC3T3-E1 cells were cultured in osteogenic differentiation medium for 10 d. The differentiated cells were transfected with OPN siRNA, stimulated by HGF or PDGF, and analyzed as in A and B. (J, K) Differentiated MC3T3-E1 cells were treated with OPN-specific siRNA or anti-OPN antibody, followed by HGF stimulation and analysis as in E and F.
Recombinant Mouse Hgf, supplied by Mitsubishi Tanabe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/recombinant+mouse+hgf/pmc05426847-179-0-6
Average 90 stars, based on 1 article reviews
recombinant mouse hgf - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mitsubishi Tanabe recombinant mouse hepatocyte growth factor (hgf)
OPN inhibits <t>HGF-</t> and PDGF-induced cellular events associated with FAK phosphorylation. (A, B) MC3T3-E1 Tet-on OPN cell lines were incubated with or without 2 μg/ml DOXY for 48 h and untreated or treated with either HGF (15 ng/ml) for 20 min or PDGF (10 ng/ml) for 10 min. The prepared cell lysates were separated by SDS–PAGE, and Western blotting was performed with the indicated antibodies. Significant difference from the control by Student’s t test (* p < 0.01). (C, D) MC3T3-E1 cells were treated with 100 ng/ml <t>recombinant</t> OPN protein for 6 h, followed by stimulation and analysis as in A and B. (E) MC3T3-E1 Tet-on OPN cell lines were treated with DOX for 48 h, followed by stimulation with HGF for 2 h. HGF-induced Vdr expression was evaluated by real-time RT-PCR. The same experiments were performed at least three times, producing consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (F) MC3T3-E1 cells were pretreated with OPN for 6 h and analyzed as in E. (G) MC3T3-E1 cells were treated with OPN for 3 h, followed by stimulation with 10 ng/ml mouse recombinant PDGF for 30 min. Cells were seeded on fibronectin-coated dishes and fixed with 10% formaldehyde at 60 min. Cells were stained to visualize the cytoplasm by eosin solution. Ten attached cells were randomly selected to measure the cell-spreading area using ImageJ software. Error bars represent SD. Statistical significance was determined by Student’s t test (* p < 0.01). (H, I) MC3T3-E1 cells were cultured in osteogenic differentiation medium for 10 d. The differentiated cells were transfected with OPN siRNA, stimulated by HGF or PDGF, and analyzed as in A and B. (J, K) Differentiated MC3T3-E1 cells were treated with OPN-specific siRNA or anti-OPN antibody, followed by HGF stimulation and analysis as in E and F.
Recombinant Mouse Hepatocyte Growth Factor (Hgf), supplied by Mitsubishi Tanabe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+hgf/recombinant+mouse+hepatocyte+growth+factor++hgf+/10__1091_slash_mbc__e16___10___0716-159-0-9
Average 90 stars, based on 1 article reviews
recombinant mouse hepatocyte growth factor (hgf) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Key Resource Table

Journal: Cell stem cell

Article Title: The mitochondrial protein OPA1 regulates the quiescent state of adult muscle stem cells

doi: 10.1016/j.stem.2022.07.010

Figure Lengend Snippet: Key Resource Table

Article Snippet: Single EDL myofibers were treated with 2 μM Mdivi-1 (Millipore Sigma; M0199), 10 μM MitoTEMPO (Millipore Sigma; SML0737), 10 or 50 μM BSO (Millipore Sigma; B2515), 10 nM (low dose) or 50 μM Rotenone (Millipore Sigma; R8875), 25nM (low dose) mito-Paraquat (Abcam, ab146819), 1 mM L-Glutathione (GSH) (Millipore Sigma; G4251), 5 mM L-Cysteine (Millipore Sigma; 5360), 5 mM Glycine (Bio-Rad; 1610717), 50 μM Antimycin A (Millipore Sigma; A8674), 5 μM Oligomycin (Millipore Sigma; O4876), 20 nM Rapamycin (Invivogen; tlrl-rap), 10 nM Torin-1 (Invivogen; inh-tor1), 40 ng/mL Recombinant Mouse HGF-A (R&D Systems; 1200-SE) or 10 ng/mL Recombinant human active HGF (Abcam; Ab632), depending on experimental design.

Techniques: Recombinant, TUNEL Assay, Isolation, Enzyme-linked Immunosorbent Assay, Microarray, Software, Microscopy, Imaging

Key Resource Table

Journal: Cell stem cell

Article Title: The mitochondrial protein OPA1 regulates the quiescent state of adult muscle stem cells

doi: 10.1016/j.stem.2022.07.010

Figure Lengend Snippet: Key Resource Table

Article Snippet: Single EDL myofibers were treated with 2 μM Mdivi-1 (Millipore Sigma; M0199), 10 μM MitoTEMPO (Millipore Sigma; SML0737), 10 or 50 μM BSO (Millipore Sigma; B2515), 10 nM (low dose) or 50 μM Rotenone (Millipore Sigma; R8875), 25nM (low dose) mito-Paraquat (Abcam, ab146819), 1 mM L-Glutathione (GSH) (Millipore Sigma; G4251), 5 mM L-Cysteine (Millipore Sigma; 5360), 5 mM Glycine (Bio-Rad; 1610717), 50 μM Antimycin A (Millipore Sigma; A8674), 5 μM Oligomycin (Millipore Sigma; O4876), 20 nM Rapamycin (Invivogen; tlrl-rap), 10 nM Torin-1 (Invivogen; inh-tor1), 40 ng/mL Recombinant Mouse HGF-A (R&D Systems; 1200-SE) or 10 ng/mL Recombinant human active HGF (Abcam; Ab632), depending on experimental design.

Techniques: Recombinant, TUNEL Assay, Isolation, Enzyme-linked Immunosorbent Assay, Microarray, Software, Microscopy, Imaging

Journal: Cell stem cell

Article Title: The mitochondrial protein OPA1 regulates the quiescent state of adult muscle stem cells

doi: 10.1016/j.stem.2022.07.010

Figure Lengend Snippet:

Article Snippet: Single EDL myofibers were treated with 2 μM Mdivi-1 (Millipore Sigma; M0199), 10 μM MitoTEMPO (Millipore Sigma; SML0737), 10 or 50 μM BSO (Millipore Sigma; B2515), 10 nM (low dose) or 50 μM Rotenone (Millipore Sigma; R8875), 25nM (low dose) mito-Paraquat (Abcam, ab146819), 1 mM L-Glutathione (GSH) (Millipore Sigma; G4251), 5 mM L-Cysteine (Millipore Sigma; 5360), 5 mM Glycine (Bio-Rad; 1610717), 50 μM Antimycin A (Millipore Sigma; A8674), 5 μM Oligomycin (Millipore Sigma; O4876), 20 nM Rapamycin (Invivogen; tlrl-rap), 10 nM Torin-1 (Invivogen; inh-tor1), 40 ng/mL Recombinant Mouse HGF-A (R&D Systems; 1200-SE) or 10 ng/mL Recombinant human active HGF (Abcam; Ab632), depending on experimental design.

Techniques: Concentration Assay, Recombinant

Fig. 5. Loss of TRPM7 impairs activation of the mTOR signaling and induction of GAlert in MuSCs. (A) Time course for induction of Trpm7 deficiency and isolation of myofibers. (B and C) Analysis of MuSCs on myofibers cultured for 30 h. (B) MuSC size: Representative YFP-positive MuSC images and size distribution (>100 cells per condi- tion). (C) pS6: Representative fluorescent images and quantification of pS6 intensity (>50 cells per condition, N = 3 mice). (D) Time course for induction of Trpm7 defi- ciency, injection of CTX, and isolation of myofibers. MuSCs on myofibers without injury was defined as quiescent satellite cells (QSCs). MuSCs on myofibers isolated from the contralateral leg of injury was defined as contralateral satellite cells (CSCs). Myofibers were isolated 4 days after CTX injection for GAlert induction. (E) Morphological evaluation of MuSCs after induction of GAlert. Phase contrast images of con (top) and cKO (bottom) MuSCs. Size distribution of QSCs and CSCs (>100 MuSCs per condition; data are individually plotted.). (F) pS6 in QSCs and CSCs: Representative images and quantification in con and cKO MuSCs (>50 cells per condition, N > 3 mice). (G) FACS histograms of MitoTracker and PyroninY staining. Gray: Unstained MuSCs; blue: con QSCs; green: con CSCs; red: cKO CSCs. (H) Time course for induction of Trpm7 defi- ciency, injection of HGFA, and isolation of myofibers. MuSCs from HGFA-treated mice were defined as HGFA for GAlert induction. PBS was used for control. (I) HGFA effect on pS6 in cKO MuSCs: Representative images and quantification of pS6 in con and cKO MuSCs after GAlert induction with HGFA (>50 cells per condition, N = 3 mice). Scale bars, 10 μm in [(B), (C), (E), (F), and (I)].

Journal: Science advances

Article Title: Mg 2+ influx mediated by TRPM7 triggers the initiation of muscle stem cell activation.

doi: 10.1126/sciadv.adu0601

Figure Lengend Snippet: Fig. 5. Loss of TRPM7 impairs activation of the mTOR signaling and induction of GAlert in MuSCs. (A) Time course for induction of Trpm7 deficiency and isolation of myofibers. (B and C) Analysis of MuSCs on myofibers cultured for 30 h. (B) MuSC size: Representative YFP-positive MuSC images and size distribution (>100 cells per condi- tion). (C) pS6: Representative fluorescent images and quantification of pS6 intensity (>50 cells per condition, N = 3 mice). (D) Time course for induction of Trpm7 defi- ciency, injection of CTX, and isolation of myofibers. MuSCs on myofibers without injury was defined as quiescent satellite cells (QSCs). MuSCs on myofibers isolated from the contralateral leg of injury was defined as contralateral satellite cells (CSCs). Myofibers were isolated 4 days after CTX injection for GAlert induction. (E) Morphological evaluation of MuSCs after induction of GAlert. Phase contrast images of con (top) and cKO (bottom) MuSCs. Size distribution of QSCs and CSCs (>100 MuSCs per condition; data are individually plotted.). (F) pS6 in QSCs and CSCs: Representative images and quantification in con and cKO MuSCs (>50 cells per condition, N > 3 mice). (G) FACS histograms of MitoTracker and PyroninY staining. Gray: Unstained MuSCs; blue: con QSCs; green: con CSCs; red: cKO CSCs. (H) Time course for induction of Trpm7 defi- ciency, injection of HGFA, and isolation of myofibers. MuSCs from HGFA-treated mice were defined as HGFA for GAlert induction. PBS was used for control. (I) HGFA effect on pS6 in cKO MuSCs: Representative images and quantification of pS6 in con and cKO MuSCs after GAlert induction with HGFA (>50 cells per condition, N = 3 mice). Scale bars, 10 μm in [(B), (C), (E), (F), and (I)].

Article Snippet: Recombinant HGFA (#1200- SE, R&D Systems) was administered to mice at a dose of 1 μg diluted in 200 μl of PBS via tail vein injection as previously described (42).

Techniques: Activation Assay, Isolation, Cell Culture, Injection, Staining, Control

Figure 3. Inhibition of MET and HGF-activation in CRTC2 cells, in vitro analysis. (A) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were then treated with each agent (final concentration of 250 nM for MET-I and 10 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of mouse recombinant pro-HGF (50 ng/mL). After incubation at 37 ◦C for 2 h, the proteins were extracted. Phosphorylation of MET and expression of total-MET, HGF, and α-tubulin were determined by immunoblot analysis. (B) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were seeded in a 96-well plate at a density of 1 × 104 cells/100 µL in FBS-free DMEM. The cells were then treated with each agent (final concentration of 20 µM for MET-I and 20 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of 50 ng/mL mouse recombinant pro-HGF, and incubated at 37 ◦C for 48 h. Cell proliferation was analyzed by detecting the absorbance at 490 nm and calculated as a ratio to the absorbance at day 0 (before administration, ** p < 0.01).

Journal: International journal of molecular sciences

Article Title: Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC.

doi: 10.3390/ijms26052308

Figure Lengend Snippet: Figure 3. Inhibition of MET and HGF-activation in CRTC2 cells, in vitro analysis. (A) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were then treated with each agent (final concentration of 250 nM for MET-I and 10 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of mouse recombinant pro-HGF (50 ng/mL). After incubation at 37 ◦C for 2 h, the proteins were extracted. Phosphorylation of MET and expression of total-MET, HGF, and α-tubulin were determined by immunoblot analysis. (B) CRTC2 cells were pre-cultured in FBS-free DMEM for 24 h. The cells were seeded in a 96-well plate at a density of 1 × 104 cells/100 µL in FBS-free DMEM. The cells were then treated with each agent (final concentration of 20 µM for MET-I and 20 µM for HGFA-I) at 37 ◦C for 2 h, followed by the addition of 50 ng/mL mouse recombinant pro-HGF, and incubated at 37 ◦C for 48 h. Cell proliferation was analyzed by detecting the absorbance at 490 nm and calculated as a ratio to the absorbance at day 0 (before administration, ** p < 0.01).

Article Snippet: Recombinant mouse HGF propeptide protein (#7058-HG) and mouse HGF protein (#2207-HG) were purchased from R&D Systems.

Techniques: Inhibition, Activation Assay, In Vitro, Cell Culture, Concentration Assay, Recombinant, Incubation, Phospho-proteomics, Expressing, Western Blot

OPN inhibits HGF- and PDGF-induced cellular events associated with FAK phosphorylation. (A, B) MC3T3-E1 Tet-on OPN cell lines were incubated with or without 2 μg/ml DOXY for 48 h and untreated or treated with either HGF (15 ng/ml) for 20 min or PDGF (10 ng/ml) for 10 min. The prepared cell lysates were separated by SDS–PAGE, and Western blotting was performed with the indicated antibodies. Significant difference from the control by Student’s t test (* p < 0.01). (C, D) MC3T3-E1 cells were treated with 100 ng/ml recombinant OPN protein for 6 h, followed by stimulation and analysis as in A and B. (E) MC3T3-E1 Tet-on OPN cell lines were treated with DOX for 48 h, followed by stimulation with HGF for 2 h. HGF-induced Vdr expression was evaluated by real-time RT-PCR. The same experiments were performed at least three times, producing consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (F) MC3T3-E1 cells were pretreated with OPN for 6 h and analyzed as in E. (G) MC3T3-E1 cells were treated with OPN for 3 h, followed by stimulation with 10 ng/ml mouse recombinant PDGF for 30 min. Cells were seeded on fibronectin-coated dishes and fixed with 10% formaldehyde at 60 min. Cells were stained to visualize the cytoplasm by eosin solution. Ten attached cells were randomly selected to measure the cell-spreading area using ImageJ software. Error bars represent SD. Statistical significance was determined by Student’s t test (* p < 0.01). (H, I) MC3T3-E1 cells were cultured in osteogenic differentiation medium for 10 d. The differentiated cells were transfected with OPN siRNA, stimulated by HGF or PDGF, and analyzed as in A and B. (J, K) Differentiated MC3T3-E1 cells were treated with OPN-specific siRNA or anti-OPN antibody, followed by HGF stimulation and analysis as in E and F.

Journal: Molecular Biology of the Cell

Article Title: Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low–molecular weight protein tyrosine phosphatase

doi: 10.1091/mbc.E16-10-0716

Figure Lengend Snippet: OPN inhibits HGF- and PDGF-induced cellular events associated with FAK phosphorylation. (A, B) MC3T3-E1 Tet-on OPN cell lines were incubated with or without 2 μg/ml DOXY for 48 h and untreated or treated with either HGF (15 ng/ml) for 20 min or PDGF (10 ng/ml) for 10 min. The prepared cell lysates were separated by SDS–PAGE, and Western blotting was performed with the indicated antibodies. Significant difference from the control by Student’s t test (* p < 0.01). (C, D) MC3T3-E1 cells were treated with 100 ng/ml recombinant OPN protein for 6 h, followed by stimulation and analysis as in A and B. (E) MC3T3-E1 Tet-on OPN cell lines were treated with DOX for 48 h, followed by stimulation with HGF for 2 h. HGF-induced Vdr expression was evaluated by real-time RT-PCR. The same experiments were performed at least three times, producing consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (F) MC3T3-E1 cells were pretreated with OPN for 6 h and analyzed as in E. (G) MC3T3-E1 cells were treated with OPN for 3 h, followed by stimulation with 10 ng/ml mouse recombinant PDGF for 30 min. Cells were seeded on fibronectin-coated dishes and fixed with 10% formaldehyde at 60 min. Cells were stained to visualize the cytoplasm by eosin solution. Ten attached cells were randomly selected to measure the cell-spreading area using ImageJ software. Error bars represent SD. Statistical significance was determined by Student’s t test (* p < 0.01). (H, I) MC3T3-E1 cells were cultured in osteogenic differentiation medium for 10 d. The differentiated cells were transfected with OPN siRNA, stimulated by HGF or PDGF, and analyzed as in A and B. (J, K) Differentiated MC3T3-E1 cells were treated with OPN-specific siRNA or anti-OPN antibody, followed by HGF stimulation and analysis as in E and F.

Article Snippet: Recombinant mouse HGF was provided by Mitsubishi Tanabe Pharma (Osaka, Japan).

Techniques: Phospho-proteomics, Incubation, SDS Page, Western Blot, Control, Recombinant, Expressing, Quantitative RT-PCR, Comparison, Staining, Software, Cell Culture, Transfection

LMW-PTP is involved in OPN-induced inactivation of osteoblast reactions. (A–C) MC3T3-E1 Tet-on Flag-LMW-PTP cell lines were incubated with or without 2 μg/ml DOXY for 48 h and either untreated or treated with LIPUS, recombinant HGF (15 ng/ml), or PDGF (10 ng/ml) for the indicated time. The levels of total and phosphorylated FAK were evaluated by Western blotting. Significant difference from the control by Student’s t test (* p < 0.01). (D) MC3T3-E1 Tet-on Flag-LMW-PTP cells were incubated with DOXY for 48 h and stimulated with LIPUS for 20 min. After additional incubation for 2 h, total RNA was isolated and reverse transcribed. Gene expression of Nos1 and Nos2 was analyzed by real-time PCR. The same experiments were performed at least three times with consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (E) MC3T3-E1 Tet-on Flag-LMW-PTP cell lines were treated with DOXY for 48 h, followed by stimulation by HGF for 2 h. Real-time PCR analyses were performed as in D. (F–J) MC3T3-E1 cells (F–I) and primary mouse osteoblasts (J) were transiently transfected with either LMW-PTP siRNA or control siRNA. Inhibitory effects of LMW-PTP siRNA on protein expression (F) were examined by Western blotting. After transfection, cells were treated with recombinant OPN for 6 h, followed by stimulation by LIPUS (G, I, J) or HGF (H). Phosphorylation of FAK (G, H) and Nos1 mRNA expression (I, J) was analyzed as in A and D.

Journal: Molecular Biology of the Cell

Article Title: Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low–molecular weight protein tyrosine phosphatase

doi: 10.1091/mbc.E16-10-0716

Figure Lengend Snippet: LMW-PTP is involved in OPN-induced inactivation of osteoblast reactions. (A–C) MC3T3-E1 Tet-on Flag-LMW-PTP cell lines were incubated with or without 2 μg/ml DOXY for 48 h and either untreated or treated with LIPUS, recombinant HGF (15 ng/ml), or PDGF (10 ng/ml) for the indicated time. The levels of total and phosphorylated FAK were evaluated by Western blotting. Significant difference from the control by Student’s t test (* p < 0.01). (D) MC3T3-E1 Tet-on Flag-LMW-PTP cells were incubated with DOXY for 48 h and stimulated with LIPUS for 20 min. After additional incubation for 2 h, total RNA was isolated and reverse transcribed. Gene expression of Nos1 and Nos2 was analyzed by real-time PCR. The same experiments were performed at least three times with consistent results. Relative mRNA expression levels in comparison with Rpl13a are shown. Error bars represent SD. Significant difference from the control by Student’s t test (* p < 0.01). (E) MC3T3-E1 Tet-on Flag-LMW-PTP cell lines were treated with DOXY for 48 h, followed by stimulation by HGF for 2 h. Real-time PCR analyses were performed as in D. (F–J) MC3T3-E1 cells (F–I) and primary mouse osteoblasts (J) were transiently transfected with either LMW-PTP siRNA or control siRNA. Inhibitory effects of LMW-PTP siRNA on protein expression (F) were examined by Western blotting. After transfection, cells were treated with recombinant OPN for 6 h, followed by stimulation by LIPUS (G, I, J) or HGF (H). Phosphorylation of FAK (G, H) and Nos1 mRNA expression (I, J) was analyzed as in A and D.

Article Snippet: Recombinant mouse HGF was provided by Mitsubishi Tanabe Pharma (Osaka, Japan).

Techniques: Incubation, Recombinant, Western Blot, Control, Isolation, Reverse Transcription, Gene Expression, Real-time Polymerase Chain Reaction, Expressing, Comparison, Transfection, Phospho-proteomics